Stocks Overview

LAST PRICE
27.4800
TODAY'S CHANGE (%)
Trending Up0.2100 (0.7701%)

Bid / Lots
27.0100/ 1
Ask / Lots
27.5800/ 1
Open / Previous Close
27.2500 / 27.2700
Day Range
Low 27.1600
High 27.7000
52 Week Range
Low 25.9200
High 34.6500
Volume
1,871,640
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Friday's close: 27.27
Time	Volume	RPRX
09:32 ET	27350	27.29
09:34 ET	4123	27.2
09:36 ET	2785	27.19
09:38 ET	4335	27.26
09:39 ET	3841	27.225
09:41 ET	7468	27.31
09:43 ET	9409	27.28
09:45 ET	4496	27.3
09:48 ET	3452	27.36
09:50 ET	2553	27.34
09:52 ET	3730	27.31
09:54 ET	3861	27.315
09:56 ET	2918	27.315
09:57 ET	6877	27.31
09:59 ET	6458	27.3
10:01 ET	6411	27.2
10:03 ET	2611	27.18
10:06 ET	1140	27.18
10:08 ET	4611	27.21
10:10 ET	15265	27.19
10:12 ET	4526	27.1699
10:14 ET	1919	27.17
10:15 ET	13979	27.215
10:17 ET	8813	27.255
10:19 ET	1518	27.26
10:21 ET	2590	27.264
10:24 ET	3700	27.3
10:26 ET	2994	27.265
10:28 ET	8427	27.28
10:30 ET	5050	27.315
10:32 ET	3030	27.335
10:33 ET	1400	27.34
10:35 ET	2481	27.325
10:37 ET	3270	27.3202
10:39 ET	10194	27.35
10:42 ET	4049	27.365
10:44 ET	22217	27.35
10:46 ET	4431	27.355
10:48 ET	1800	27.355
10:50 ET	1624	27.34
10:51 ET	2682	27.375
10:53 ET	3716	27.305
10:55 ET	1391	27.295
10:57 ET	3466	27.285
11:00 ET	5507	27.285
11:02 ET	1616	27.29
11:04 ET	2302	27.28
11:06 ET	7968	27.325
11:08 ET	4086	27.31
11:09 ET	200	27.3065
11:11 ET	4381	27.305
11:13 ET	3924	27.33
11:15 ET	8210	27.33
11:18 ET	26277	27.3535
11:20 ET	3937	27.38
11:22 ET	5726	27.375
11:24 ET	4667	27.395
11:26 ET	1325	27.375
11:27 ET	1000	27.37
11:29 ET	2590	27.375
11:31 ET	5262	27.39
11:36 ET	4038	27.425
11:38 ET	7118	27.465
11:40 ET	7374	27.4402
11:42 ET	3201	27.44
11:44 ET	1688	27.455
11:45 ET	3792	27.44
11:47 ET	5117	27.47
11:49 ET	8736	27.475
11:51 ET	25065	27.44
11:54 ET	4967	27.485
11:56 ET	8718	27.517
11:58 ET	6768	27.485
12:00 ET	600	27.485
12:02 ET	10491	27.525
12:03 ET	45868	27.585
12:05 ET	8334	27.605
12:07 ET	5216	27.6
12:09 ET	2329	27.62
12:12 ET	3570	27.615
12:14 ET	5720	27.665
12:16 ET	21781	27.615
12:18 ET	6169	27.64
12:20 ET	1101	27.635
12:21 ET	4875	27.61
12:23 ET	1122	27.57
12:25 ET	1016	27.5542
12:27 ET	10040	27.5
12:30 ET	3546	27.505
12:32 ET	1900	27.5
12:34 ET	2746	27.4501
12:36 ET	1959	27.455
12:38 ET	1503	27.455
12:39 ET	1810	27.455
12:41 ET	5194	27.455
12:43 ET	2000	27.465
12:45 ET	1714	27.44
12:48 ET	522	27.445
12:50 ET	2403	27.43
12:52 ET	100	27.43
12:54 ET	1160	27.435
12:56 ET	5593	27.445
12:57 ET	2262	27.425
12:59 ET	2815	27.46
01:01 ET	2000	27.44
01:03 ET	6256	27.42
01:06 ET	1724	27.43
01:08 ET	800	27.42
01:10 ET	3764	27.43
01:12 ET	4011	27.4203
01:14 ET	2138	27.435
01:15 ET	700	27.435
01:17 ET	2563	27.42
01:19 ET	1304	27.435
01:21 ET	5553	27.4302
01:24 ET	4443	27.449
01:26 ET	7605	27.46
01:28 ET	824	27.455
01:30 ET	3999	27.475
01:32 ET	4384	27.45
01:33 ET	2069	27.435
01:35 ET	725	27.435
01:37 ET	1089	27.425
01:39 ET	2021	27.41
01:42 ET	5797	27.425
01:44 ET	2000	27.435
01:46 ET	3341	27.44
01:48 ET	6211	27.435
01:50 ET	1739	27.455
01:51 ET	2676	27.45
01:53 ET	2968	27.425
01:55 ET	3507	27.455
01:57 ET	2668	27.4412
02:00 ET	1151	27.44
02:02 ET	3214	27.465
02:04 ET	1200	27.46
02:06 ET	3634	27.47
02:08 ET	10060	27.49
02:09 ET	4468	27.505
02:11 ET	4583	27.48
02:13 ET	1800	27.48
02:15 ET	2936	27.475
02:18 ET	4242	27.475
02:20 ET	5107	27.5
02:22 ET	700	27.495
02:24 ET	8613	27.535
02:26 ET	3797	27.535
02:27 ET	800	27.535
02:29 ET	4872	27.53
02:31 ET	1955	27.545
02:33 ET	4766	27.52
02:36 ET	4603	27.53
02:38 ET	520	27.535
02:40 ET	4761	27.54
02:42 ET	861	27.55
02:44 ET	6908	27.54
02:45 ET	2500	27.555
02:47 ET	3432	27.535
02:49 ET	2128	27.52
02:51 ET	5199	27.525
02:54 ET	4472	27.49
02:56 ET	4269	27.47
02:58 ET	3345	27.465
03:00 ET	900	27.46
03:02 ET	4164	27.465
03:03 ET	2292	27.465
03:05 ET	2200	27.465
03:07 ET	2571	27.45
03:09 ET	11384	27.51
03:12 ET	3283	27.5
03:14 ET	1004	27.51
03:16 ET	16091	27.495
03:18 ET	2632	27.49
03:20 ET	6017	27.515
03:21 ET	5076	27.49
03:23 ET	2871	27.465
03:25 ET	3717	27.46
03:27 ET	3630	27.45
03:30 ET	13879	27.47
03:32 ET	2805	27.45
03:34 ET	4378	27.43
03:36 ET	9378	27.435
03:38 ET	4603	27.455
03:39 ET	4564	27.44
03:41 ET	5094	27.43
03:43 ET	10670	27.43
03:45 ET	16456	27.45
03:48 ET	12555	27.445
03:50 ET	6498	27.455
03:52 ET	23034	27.455
03:54 ET	35128	27.4
03:56 ET	61153	27.475
03:57 ET	48151	27.47
03:59 ET	56874	27.48

Data delayed at least 15 minutes.

May 17, 2024
- DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones
  7:31AM ET on Friday May 17, 2024 by Dow Jones
May 13, 2024
- Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones
  8:15AM ET on Monday May 13, 2024 by Dow Jones
May 9, 2024
- Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
  7:00AM ET on Thursday May 09, 2024 by Dow Jones
- *DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones
  7:00AM ET on Thursday May 09, 2024 by Dow Jones
- Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones
  6:45AM ET on Thursday May 09, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRPRX Royalty Pharma PLC	16.3B	15.4x	+1.83%
United StatesAMRX Amneal Pharmaceuticals Inc	2.1B	-11.9x	---
United StatesCTLT Catalent Inc	10.0B	-8.5x	---
United StatesJAZZ Jazz Pharmaceuticals PLC	6.9B	22.4x	-3.53%
United StatesMCKPF Mallinckrodt PLC	1.6M	0.0x	---
United StatesROIV Roivant Sciences Ltd	9.0B	2.2x	---
As of 2024-05-20

Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.

Contact Information

Headquarters: 110 East 59th StreetNEW YORK, NY, United States 10022
Phone: 212-883-0200
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Pablo Legorreta
Vice Chairman, Executive Vice President: Christopher Hite
Chief Financial Officer, Executive Vice President: Terrance Coyne
Executive Vice President - Investments and Chief Legal Officer: George Lloyd
Executive Vice President - Research and Investments: Marshall Urist

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$16.3B
Revenue (TTM)	$2.2B
Shares Outstanding	597.4M
Dividend Yield	3.06%
Annual Dividend Rate	0.8400 USD
Ex-Dividend Date	05-16-24
Pay Date	06-14-24
Beta	0.46
EPS	$1.78
Book Value	$14.61
P/E Ratio	15.4x
Price/Sales (TTM)	7.3
Price/Cash Flow (TTM)	13.7x
Operating Margin	41.96%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Royalty Pharma PLC
NASDAQ:RPRXUnited States

Search Criteria

Charts

Recent News

May 17, 2024

DJ S&P 500 Futures Steady In Premarket Trading; RBC Bearings, GameStop Lag, from 7:31AM ET on Friday May 17, 2024 by Dow Jones

May 13, 2024

Royalty Pharma to Present at Upcoming Investor Conferences, from 8:15AM ET on Monday May 13, 2024 by Dow Jones

May 9, 2024

Royalty Pharma Reports First Quarter 2024 Results, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones

*DJ Royalty Pharma 1Q Net $5M >RPRX, from 7:00AM ET on Thursday May 09, 2024 by Dow Jones

Royalty Pharma to Acquire Royalty Interest in Sanofi's Frexalimab, from 6:45AM ET on Thursday May 09, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar